PC3I News
A $2.5 million gift from the Bristol Myers Squibb foundation will help establish a Geriatric Oncology Program to improve care for older adults with cancer at the Penn Medicine Princeton Cancer Center. The program will be led by PC3I Faculty Ramy Sedhom, MD.
According to Princeton Health CEO James Demetriades, approximately 70% of the center’s patients with cancer are ages 65 years or older, and these patients’ care needs often vary due to differences in social, cultural, spiritual, emotional, and financial factors. The new Geriatric Oncology Program will take a holistic approach to supportive care, and focus on designing personalized cancer care plans for patients 65 years or older. Sedhom, who is also a co-leader of the Penn Medicine Geriatric Oncology service line, will oversee the center and help expand geriatric competencies of Princeton Health staff through education and increasing outreach to seniors in the community.
The program hopes to continue helping patients like Mimi Reed, who was diagnosed with cancer at age 87 and treated with her individual goals and preferences taken into consideration. Thanks to the Geriatric Oncology program at Princeton, she was able to maintain her independence and have ongoing discussions with doctors like Sedhom about her treatment.
In an interview with Penn Medicine, Reed shared, “Dr. Sedhom is always so kind. He is an excellent listener, and from the beginning he had exceptional interest in what was on my mind.”
18 months after her diagnosis, Reed is now cancer-free and grateful for the attentive care she received at Penn’s Princeton Medical Center.
For more information, read the full press release.
Related News
PC3I News
Cancer Service Line & PC3I Select 2024 Innovation Accelerator Project
04.22.2024
The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) have announced the selection of the 2024 Penn Cancer Innovation Accelerator project. The chosen project, submitted by Katie Boyk, BS, MHA, will identify solutions to improve cancer care scheduling workflows for patients, clinicians, and staff.
PC3I News
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation Unveil New Collaborative Relationship
02.06.2024
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation announce an academic-community oncology innovation partnership to improve cancer care delivery.
PC3I News
PC3I Leadership Presents at 2023 AORTIC International Conference on Cancer in Africa
12.05.2023
PC3I Associate Director Surbhi Grover and Deputy Director Katharine Rendle presented research at the 14th AORTIC International Conference on Cancer in Africa, which took place in Dakar, Senegal.